HOPE KOONTZ: Open Payments
NPI 1366952269 · LIGONIER, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$465 in 25 payments from 13 companies in 2025. Trend: 2023 $574 · 2024 $453 · 2025 $465
Food & beverage: $465
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $94 |
| ABBVIE INC. | 5 | $92 |
| Inspire Medical Systems, Inc. | 2 | $51 |
| Abbott Laboratories | 2 | $38 |
| Lilly USA, LLC | 2 | $33 |
| GlaxoSmithKline, LLC. | 2 | $30 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $22 |
| Xeris Pharmaceuticals, Inc. | 1 | $20 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $20 |
| Axsome Therapeutics, Inc. | 1 | $19 |
Products named: VRAYLAR, Wegovy, INSPIRE, FREESTYLE LIBRE 3, JARDIANCE, XIFAXAN, GVOKE HYPOPEN, Auvelity.
Industry payments across IN — which companies pay providers there.
